General MedicationsINJECTIONGeneric

PAMIDRONATE DISODIUM

Standard Dose

30MG/10ML (3MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 078942 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 30MG/10ML (3MG/ML) Sponsor AM REGENT Submission history Latest submission status date: 2015-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 078942 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 30MG/10ML (3MG/ML) Sponsor AM REGENT Submission history Latest submission status date: 2015-10-30 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.